NIVF Company Profile and Key Details

NewGenIvf Group Limited earnings surprise history is a mixed track record. The quarter that ended April 01, 2026, missed forecasts by -104.36%.

NIVF has shown weak momentum, losing -24.16% over the past week and -92.84% over the past quarter, though year-to-date performance is down -36.22%. Short-term trend indicators are bullishly aligned (SMA20 -16.38%, SMA50 -49.77%, SMA200 -98.12%). The stock’s 14-day RSI is 32.27 (weak momentum), while the ATR of 0.2 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -99.96% below its high and over 15.01% above its low. Average 10-day trading volume of 5.62 million shares is significantly above the 3-month average of 628.60 thousand, indicating heightened recent market interest.

NewGenIvf Group Limited has 1.83 million shares outstanding. The public float is 22.54 thousand shares, elevated short interest at 5.67% of float. This equals 103.64 thousand shares. The short ratio is 0.15 days. Institutional investors hold 0.46% of the float. Insiders own 0.04%.

NewGenIvf Group Limited last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $0.92. This means the shares are trading above this model’s fair value.

NewGenIvf Group Limited (NASDAQ:NIVF) closed at $1.69 USD, losing -$0.02 (-1.17%) from the previous close of $1.71. The stock is currently mid-range between its 52-week high and low $1.33 and $1.84 thousand. With a market capitalization of about $960.67 thousand, NewGenIvf Group Limited is classified as a micro-cap and shows lower-than-market volatility (beta ~0.03). Key stats such as the average daily volume over the past year has been around 545.26 thousand shares, trading with heavier-than-usual volume. Headquartered in Bangkok, None, NewGenIvf Group Limited operates in the Healthcare sector and the Medical - Healthcare Plans industry. Led by CEO Wing Fung Siu, the company employs approximately 76 people and listed since March 18, 2022. NewGenIVF Group Ltd. operates as an assisted reproductive services provider.

Our AI price prediction model suggests that NewGenIvf Group Limited stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected increase of 1.18%, with price expected at $1.71 by May 18, 2026, within a range of $1.42 to $1.97 3-Month Outlook: Projected fall of -100.0%, reaching $0.00 by July 31, 2026, with a range of $0.00 to $721.30. 1-Year Outlook: Projected gain of 25.44%, with price at $2.12 by May 04, 2027, within a range of $0.00 to $7.30 thousand.

NewGenIvf Group Limited (NASDAQ:NIVF) shares are down -36.22% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows NewGenIvf Group Limited trading at a premium to the broader market with a P/E of 0.1. Our AI forecast model points to short-term strength (1.18% over two weeks), a medium-term fall (-100.0% over three months), and a longer-term gain (25.44% over one year), with expected trading ranges indicating moderate volatility.

NewGenIvf Group Limited trades at a P/E ratio of 0.1, slightly below the S&P 500 average, with a price-to-sales ratio of 0.33 and a price-to-book ratio of 0.03 suggesting the stock is closer to book value. The P/FCF stands at -0.14, also above market averages.